A previous report described an intracellular factor (differentiation-inducing factor I, or DIF-I) that seems to play a role in erythroid differentiation in mouse erythroleukemia (MEL) cells. We have detected another erythroidinducing factor in cell-free extracts from dimethyl sulfoxide-or hexamethylenebis(acetamide)-treated MEL cells, which acts synergistically with DIF-I. The partially purified factor (termed DIF-TI) triggered erythroid differentiation when introduced into undifferentiated MEL cells that had been potentiated by the induction of DIF-I. The activity in the extracts appeared in an inducible manner after addition of dimethyl sulfoxide or hexamethylenebis(acetamide), reached a maximum at 6 hr, and then rapidly decreased. The induction was inhibited by phorbol 12-myristate 13-acetate and also by cycloheximide. No induction was observed in a mutant MEL cell line defective in erythroid differentiation. These characteristics are consistent with the supposition that DIF-1I is one of the putative dimethyl sulfoxide-inducible factors detected in previously reported cell-fusion and cytoplast-fusion experiments. The role of DIF-II in MEL-cell differentiation and in vitro differentiation in general is discussed.
(termed DIF-TI) triggered erythroid differentiation when introduced into undifferentiated MEL cells that had been potentiated by the induction of DIF-I. The activity in the extracts appeared in an inducible manner after addition of dimethyl sulfoxide or hexamethylenebis(acetamide), reached a maximum at 6 hr, and then rapidly decreased. The induction was inhibited by phorbol 12-myristate 13-acetate and also by cycloheximide. No induction was observed in a mutant MEL cell line defective in erythroid differentiation. These characteristics are consistent with the supposition that DIF-1I is one of the putative dimethyl sulfoxide-inducible factors detected in previously reported cell-fusion and cytoplast-fusion experiments. The role of DIF-II in MEL-cell differentiation and in vitro differentiation in general is discussed.
Upon exposure to a variety of agents such as dimethyl sulfoxide (Me2SO) (1) , hexamethylenebis(acetamide) (HMBA) (2) , and butyric acid (3, 4) , mouse erythroleukemia (MEL) cells differentiate in vitro to a cell type having the characteristics of erythroid cells. This system has been used as a model not only for terminal erythroid differentiation but also for in vitro differentiation in general. There are several reports regarding possible molecular events responsible for the in vitro MEL cell differentiation. These events include DNA "demethylation" processes (5, 6) , single-strand breaks in chromosomes (7) (8) (9) , conformational changes in chromatin structure (10, 11) , changes in polyamine metabolism (12, 13) , and expression or suppression of specific oncogenes (14) (15) (16) (17) (18) (19) (20) (21) .
By use of cell fusion, previous work showed the erythroid differentiation in MEL cells to be a synergistic result of at least two distinctive intracellular reactions (22) ; one originating from the inhibition or cessation of DNA replication and the other involving a transmembrane reaction triggered by the majority of inducing agents such as Me2SO or HMBA. Further studies employing cytoplast fusion as well as cell fusion (23, 24) revealed the following characteristics. The former reaction is inducible but not specific to MEL cells. The latter, which is specific to MEL cells, is also inducible accompanying de novo protein synthesis, although the induced activity remains in the cells only transiently. The induction is inhibited by tumor-promoting phorbol esters.
More recent studies dealt with a protein factor of cytoplasmic origin that seems to be responsible for the first reaction (25) . The factor can be induced in several mouse cell lines, including nonerythroid cells, following treatment of the cells with agents that affect or disturb DNA replication. Upon introduction into undifferentiated MEL cells, this factor, now designated DIF-I (differentiation-inducing factor I), triggers erythroid differentiation quite efficiently provided the cells have been potentiated by the induction of the second reaction.
Using an experimental strategy similar to the one for isolating DIF-I, we were able to demonstrate the presence of a factor in the cell-free extracts that exhibits a number of characteristics similar to those of the second factor implicated by the previous cell-fusion and cytoplast-fusion experiments. Here we report the basic characteristics of the second differentiation-inducing factor, DIF-Il, for erythroid differentiation. A preliminary report of this study has appeared in abstract form (26) .
MATERIALS AND METHODS
Materials. L-a-Lysophosphatidylcholine (lysolecithin), phenylmethylsulfonyl fluoride, dithiothreitol, aminopterin, hypoxanthine, and thymidine were purchased from Sigma; ouabain from Boehringer-Mannheim Yamanouchi (Tokyo); and mitomycin C from Kyowa Hakko (Tokyo). DEAE (20 x 100 mm) that had been equilibrated with basal buffer. After the column was washed with 150 ml of basal buffer, DIF-II was eluted with 150 ml of basal buffer containing 50 mM NaCl. Sometimes, the column was further subjected to basal buffer solutions containing higher concentrations of NaCI. Fractions that exhibited DIF-II activity were pooled (-8 ml), dialyzed against basal buffer for 6 hr, and concentrated severalfold in a Minicon (Amicon B-15). Protein concentrations were determined by a protein assay kit (Bio-Rad). All manipulations were carried out at 0-4°C, unless otherwise specified.
Assay for Erythroid-Inducing Activity. The erythroid-inducing activity of DIF-II was assayed as described (25, 28) , with the following modification. MEL DS19 cells grown to confluence were collected by centrifugation (500 x g, 5 min), washed once with phosphate-buffered saline, and resuspended in phosphate-buffered saline at S x 106 cells per ml. Two milliliters of the sample was then transferred to a plastic Petri dish (60-mm diameter) and irradiated (20 J/m2) under a germicidal UV lamp (Toshiba GL15, 15-W). After centrifugation, the cells were resuspended in minimal essential medium/12% fetal bovine serum at 8 x 105 cells per ml and incubated for 15 hr at 37°C in a CO2 incubator. The cells (total 5 x 106) were then collected by centrifugation (500 x g, 10 min) and washed twice with cold phosphate-buffered saline.
To the sedimented cells, 1 ml of cold (00C) L-a-lysophosphatidylcholine solution (4.2 ,g/ml in minimal essential medium) was added and the cells were thoroughly mixed using a Pasteur pipette. The (24) . The extracts were then introduced into undifferentiated MEL cells that had been exposed to UV light (20 J/m2), thereby maximizing the production of DIF-I, which should act synergistically with the Me2SO-inducible factor for MELcell differentiation (25) . For introducing the extracts into the cells, we employed a procedure to make the cells permeable to protein molecules (28) , modified slightly from the original protocol successfully applied for the isolation of DIF-I (25) . Although no erythroid-inducing activity was detected in the crude cytosol, an erythroid-inducing activity (assayed by hemoglobin accumulation) was detected in the eluate (50 mM NaCl) after a stepwise elution of the cytosol from a DEAE column (Fig. 1B) . No such activity was detected in the same eluate of the cytosol prepared from control cells (no Me2SO treatment, Fig. 1A ). As reported previously (25) , DIF-I activity, which is induced by either UV irradiation or mitomycin C, is eluted with 250 mM NaCI from a DEAE column. As shown in Fig. 2 , the Me2SO-inducible activity was not detected without UV treatment of recipient cells, suggesting that the induction of DIF-I in recipient cells is required for detection of the activity in the extracts. Fig. 2 also shows that the activity was observed only when the recipient cells were made permeable to protein molecules. Apparently, the factor must be taken up by the cells to exert the activity.
We prepared cytosol from MEL cells that had been treated with various inducing agents and inhibitors and from nonerythroid FM3A cells (a cell line derived from a mouse mammary gland tumor and used for large-scale preparation of DIF-I). The cytosol from each cell preparation was applied to a DEAE column and the erythroid-inducing activities in the 50 mM eluate were examined. In addition to Me2SO (Fig. 3B) , the activity was also induced by HMBA (Fig. 3C) , another potent inducer of erythroid differentiation (2) . On the other Erythroid-inducing activity in cytosol subjected to DEAE column chromatography. MEL 11A2 cells were incubated for 6 hr in the absence (A) or presence (B) of 1.8% Me2SO. The cytosol fraction ('600 mg of protein) was applied to a DEAE-cellulose column (20 x 80 mm) and eluted in a stepwise manner with 80 ml each of 50 mM, 150 mM, and 250 mM NaCl in basal buffer. Samples (20 ,ul) 2 . Detection of erythroid-inducing activity under various assay conditions. MEL 11A2 cells were incubated for 6 hr in the presence of 1.8% Me2SO. The cytosol fraction (-120 mg of protein) was applied to a DEAE column (12 x 86 mm) and eluted with 50 mM NaCI in basal buffer. From each fraction (1.25 ml), samples (20 ,l) were taken and assayed for erythroid-inducing activity (shown as in Fig. 1 ) on DS19 cells that had been irradiated by UV light and permeabilized to proteins (9) , that had been irradiated but not permeabilized (o), that had not been irradiated but had been permeabilized (A), or that had been neither irradiated nor permeabilized (A). Protein concentration of each fraction (n) is shown.
hand, no activity was detected in the eluate prepared from MEL cells that had been treated with Me2SO in the presence of PMA, a tumor-promoting phorbol ester and specific inhibitor of erythroid differentiation of MEL cells (Fig. 3D) . There was also no activity detected in the 50 mM eluate from cells treated with Me2SO plus cycloheximide, an inhibitor of protein synthesis (Fig. 3E) . No activity was induced in mouse nonerythroid FM3A cells by Me2SO (Fig. 3F) . These characteristics associated with induction ofthe activity are similar to those of the putative second intracellular factor implicated from the previous cell-fusion and cytoplast-fusion experiments: (i) the factor acts synergistically with DIF-I, (ii) the factor is induced by Me2SO or HMBA, (iii) induction is inhibited by PMA, (iv) induction requires de novo protein synthesis, and (v) induction is specific to MEL cells. We have Induction Kinetics of DIF-I. We examined the time course for the appearance of DIF-I1 in the cytosol. MEL cells were exposed to 1.8% Me2SO and, at various time intervals, the cytosol was prepared and the 50 mM NaCl eluate from the DEAE column was assayed for activity. As shown in Fig. 4 , the activity apparently began to appear soon after addition of Me2SO, reached a maximum at 6 hr of incubation, and decreased after 10 hr. It then remained at a low or nondetectable level for at least the next 30 hr. The kinetics, especially with regard to the transient nature of DIF-TI, were very similar to those revealed by the cytoplast-fusion experiments on the potential level induced by Me2SO or HMBA (24) . We prepared cytosol from DR1 cells that had been exposed to Me2SO for 6 hr and assayed the DIF-II activity in the 50 mM DEAE eluate. None was detected in this fraction (Fig.  5A) . On the other hand, when cytosol was prepared from mitomycin C-treated DR1 cells and assayed for DIF-I activity after DEAE chromatography, a normal level of DIF-I activity was detected in the 250 mM eluate where DIF-I was expected to be eluted (Fig. SB) (25) . Thus, DR1 cells are apparently impaired in the process leading to the induction of DIF-II. This is consistent with the results of the cell-fusion experiments described above. These experiments provide further evidence that DIF-II is involved in in vitro erythroid differentiation by Me2SO or HMBA.
We examined the distribution of DIF-II activity among subcellular fractions. MEL cells were incubated with 1.8% Me2SO for 6 hr, and three subcellular fractions (nuclei, mitochondria and membrane fragments, and cytosol) were obtained by differential centrifugations. The particulate fractions were further treated with high concentrations of NaCl (0.3 M for nuclei and 0.5 M for membranes and mitochondria 10 5 10 Fraction No. after sonication), and the activity in the extracts was examined. More than 93% of the activity was present in the cytosol fraction (data not shown), consistent with previous cytoplastfusion experiments in which Me2SO-induced activity was located in cytoplasts (24) .
Effect of DIF-Il Concentration on Erythroid Induction. Fig.  6 shows the dose-response curve for partially purified DIF-II used for the induction of erythroid cells. The cells were incubated in the presence of various concentrations of DIF-II (50 mM eluate from a DEAE column) and the percentage of benzidine-positive cells was determined 5 by Me2SO or HMBA; its induction was inhibited by PMA and did not take place in a mutant MEL cell unable to undergo erythroid differentiation. Chromatographic behavior also distinguishes DIF-II from DIF-I. The detection of a cytosolic factor (DIF-II) whose characteristics agree almost completely with those of the putative factor implicated from the previous cell-fusion and cytoplastfusion experiments further supports the view that the in vitro terminal differentiation of MEL cells results from the synergistic action of two distinctive cellular reactions (7, 8, (22) (23) (24) . In fact, we believe that exploiting this view to the full has made possible the detection and isolation of these two intracellular factors. For assay of DIF-II, we used recipient MEL cells in which one of the reactions had been fully induced; thus these cells had been sensitized to the factor(s) responsible for the other reaction. Neither DIF-II nor DIF-I Proc. Natl. Acad. Sci. USA 84 (1987) 0 20 30 activity was detected in the extracts without such recipientcell sensitization. How universal is the role played by DIF-I1 in inducing in vitro cellular differentiation? Me2SO and HMBA are the two agents most commonly used for inducing in vitro MEL differentiation; besides MEL cells, these agents induce differentiation in a number of other cell lines (31) (32) (33) (34) . Therefore, although the differentiation-inducing activity associated with DIF-II was examined only in MEL cells, it is reasonable to suggest that DIF-Il might also have a role in the in vitro differentiation of other cell lines that respond to Me2SO and HMBA.
We do not know how DIF-I1 triggers the erythroid differentiation or how it acts synergistically with DIF-I. In a limited number of experiments, no enzymatic activity (topoisomerase or DNase) was found to be associated with DIF-I or DIF-I. The discovery of any enzymatic activity and of any possible interaction between the two factors, along with the cloning of the genes that encode these factors, would be important for elucidating the role that these factors play in cellular differentiation.
